Indeed, shRNA silencing of REG1CP reduced REG3A expression at both the transcript and protein levels in LIM1215 and HT-29 colon cancer cells that expressed relatively high levels of REG1CP among a panel of colon cancer cell lines (Fig. 2a–c and Supplementary Fig. 1C). This evidence concerns the gene REG3A and malignant colon neoplasm.